-
It has been two years since a "black box" warning was added to the labeling for the contraceptive injection depot medroxyprogesterone acetate.
-
A recent survey of 100 public and private colleges found that many facilities may not be making the grade when it comes to providing condom availability and sexual health information.
-
In the final days of the 107th Congress, Congressional Democrats introduced two competing bills with a common goal: to reduce the number of abortions in this country.
-
Take a look around your family planning facility staff. Are there many new hires, or is the landscape comprised of seasoned veterans?
-
The Centers for Disease Control and Prevention (CDC) is recommending that voluntary HIV screening become a routine part of medical care for all patients ages 13 to 64.
-
A new analysis indicates that the prevalence of herpes simplex virus Type 2 (HSV-2) is dropping in the United States.
-
Does the condom program at your clinic consist of filling a bowl with one style of condoms in the waiting room? If so, you may want to rethink your strategy.
-
-
In a multi-center, double-blind, placebo-controlled crossover study, drospirenone 3 mg plus ethinyl estradiol 20 micrograms was administered for 24 days per month to patients with premenstrual dysphoric disorder (PMDD) according to criteria established in the Diagnostic and Statistical Manual IV.
-
In a prospective, randomized trial, both norethindrone 1 mg/ethinyl estradiol 35 mg taken three times a day initially as well as medroxyprogesterone acetate 20 mg t.i.d. initially were comparably effective and reasonably well tolerated.
